[1] Weiss RJ, Thorsell M, Stark A, et al. 2- to 9-year outcome of stemmed total knee arthroplasty. Similar failure rates in patients when used primary or as a revision. Acta Orthop. 2014;85(6):609-613. [2] Dale H, Hallan G, Hallan G, et al. Increasing risk of revision due to deep infection after hip arthroplasty. Acta Orthop. 2009;80(6):639-645. [3] Martínez-Pastor JC, Maculé-Beneyto F, Suso-Vergara S. Acute infection in total knee arthroplasty: diagnosis and treatment. Open Orthop J. 2013;7:197-204. [4] Crowninshield RD, Rosenberg AG, Sporer SM. Changing demographics of patients with total joint replacement. Clin Orthop Relat Res. 2006;443:266-272. [5] Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15(2):167-193. [6] Gilbert P, Collier PJ, Brown MR. Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response. Antimicrob Agents Chemother. 1990;34(10): 1865-1868. [7] Donlan RM. Biofilms and device-associated infections. Emerg Infect Dis. 2001;7:277-281. [8] Park J, Bauer S, Schmuki P, von der Mark K. Narrow window in nanoscale dependent activation of endothelial cell growth and differentiation on TiO2 nanotube surfaces. Nano Lett. 2009;9(9): 3157-3164. [9] Park J, Bauer S, von der Mark K, et al. Nanosize and vitality: TiO2 nanotube diameter directs cell fate. Nano Lett. 2007;7(6):1686-1691. [10] Popat KC, Leoni L, Grimes CA, et al. Influence of engineered titania nanotubular surfaces on bone cells. Biomaterials 2007;28:3188-3197. [11] Brammer KS, Oh S, Cobb CJ, et al. Improved bone-forming functionality on diameter-controlled TiO(2) nanotube surface. Acta Biomater. 2009;5(8):3215-3223. [12] Bjursten LM, Rasmusson L, Oh S, et al. Titanium dioxide nanotubes enhance bone bonding in vivo. J Biomed Mater Res A. 2010;92(3): 1218-1224. [13] Zhang HZ, Sun Y, Tian A, et al. Improved antibacterial activity and biocompatible on the vancomycin-loaded TiO2 nanotubes: in vivo and in vitro studies, International J Nanomed 2013;8:4379-4389. [14] Cook JL, Scott RD, Long WJ. Late hematogenous infections after total knee arthroplasty: experience with 3013 consecutive total knees. J Knee Surg. 2007;20(1):27-33. [15] Schmalzried TP, Amstutz HC, Au MK, et al. Etiology of deep sepsis in total hip arthrosplasty. The significance of hematogenous and recurrent infections. Clin Orthop Rel Res. 1992;280:200-207.[16] Zhang E, Li F, Wang H, et al. A new antibacterial titanium-copper sintered alloy: Preparation and antibacterial property. Mater Sci Eng C Mater Biol Appl. 2013;33(7):4280-4287. [17] Tian XB, Wang ZM, Yang SQ, et al. Antibacterial copper-containing titanium nitride films produced by dual magnetron sputtering, Surf Coat Technol. 2007;201:8606-8609.[18] Secinti KD, Ayten M, Kahilogullari G, et al. Antibacterial effects of electrically activated vertebral implants. J Clin Neurosci 2008;15(4): 434-439. [19] Wan YZ, Xiong GY, Liang H, et al. Modi?cation of medical metals by ion implantation of copper. Appl Surf Sci. 2007;253:9426-9429. [20] Colon G, Ward BC, Webster TJ. Increased osteoblast and decreased Staphylococcus epidermidis functions on nanophase ZnO and TiO2. J Biomed Mater Res A. 2006;78(3):595-604. [21] Melaiye AYW. Silver and its application as an antimicrobial agent. Expert Opin Ther Pat. 2005;15:125-130. [22] Zheng X, Chen Y, Xie Y, et al. Antibacterial property and biocompatibility of plasma sprayed hydroxyapatite/silver composite coatings. Repentu Jishu Zazhi. 2009;18:463.[23] Azam A, Ahmed AS, Oves M, et al. Size-dependent antimicrobial properties of CuO nanoparticles against Gram-positive and -negative bacterial strains. Int J Nanomedicine. 2012;7:3527-3535. [24] Tsao N, Luh TY, Chou CK, et al. In vitro action of carboxyfullerene. J Antimicrob Chemother. 2002;49(4):641-649. [25] Ercan B, Taylor E, Alpaslan E et al. Diameter of titanium nanotubes influences anti-bacterial efficacy. Nanotechnology. 2011;22(29):295102. [26] Helmus MN, Gibbons DF, Cebon D. Biocompatibility: meeting a key functional requirement of next-generation medical devices. Toxicol Pathol. 2008;36(1):70-80. [27] Puckett SD, Taylor E, Raimondo T, et al. The relationship between the nanostructure of titanium surfaces and bacterial attachment. Biomaterials. 31:706-713. [28] Oh SH, Finõnes RR, Daraio C, et al. Growth of nano-scale hydroxyapatite using chemically treated titanium oxide nanotubes. Biomaterials. 2005;26(24):4938-4943. [29] Kim HM, Himeno T, Kawashita M, et al. Surface potential change in bioactive titanium metal during the process of apatite formation in simulated body fluid. J Biomed Mater Res. 2003;67A(4):1305-1309.[30] Qian T, Wang Y. Micro/nano-fabrication technologies for cell biology. Med Biol Eng Comput. 2010;48(10):1023-1032. [31] Meyer U, Büchter A, Wiesmann HP, et al. Basic reactions of osteoblasts on structured material surfaces. Eur Cell Mater. 2005;9: 39-49. [32] Beutner R, Michael J, Schwenzer B, et al. Biological nano-functionalization of titanium-based biomaterial surfaces: a flexible toolbox. J R Soc Interface. 2010;6;7 Suppl 1:S93-S105.[33] Popat KC, Eltgroth M, Latempa TJ, et al. Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials. 2007;28(32):4880-4888. [34] Ren L, Wong HM, Yan CH, et al. Osteogenic ability of Cu-bearing stainless steel. J Biomed Mater Res B Appl Biomater. 2015; 103(7):1433-1444.[35] Stoodley P, Ehrlich GD, Sedghizadeh PP, et al. Orthopaedic biofilm infections. Curr Orthop Pract. 2011;22(6):558-563. [36] Hetrick EM, Schoenfisch MH. Reducing implant-related infections: active release strategies. Chem Soc Rev. 2006;35(9):780-789. |